http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
2-weekly vs 3-weekly docetaxel in CRPC: A retrospective, single-institute study
Papantoniou, D.; Pettersson, L. Elsevier Science B.V., Amsterdam. 2018 p.e2877
Abiraterone acetate vs. Enzalutamide for metastatic castration-resistant prostate cancer
Tavares Machado, C.; Sousa, D.G.; Mendes, G.; Reis, D.O.; Carneiro, D.; Teves, F.T.; Febra, J.; Castro, A.; Fraga, A. Elsevier Science B.V., Amsterdam. 2018 p.e2864
Accurate risk assessment of patients with pathologic T3aN0M0 renal cell carcinoma
Jong Jin, O.; Byun, S.-S.; Yu, H.Y.; Kim, T.J.; Hong, S.K.; Kim, J.J. Elsevier Science B.V., Amsterdam. 2018 p.e2922-e2923
Waigankar, S.; Thyavihally Boregowda, Y.; Pednekar, A.; Ramani, S. Elsevier Science B.V., Amsterdam. 2018 p.e2989
Active Surveillance in Low-risk Prostate Cancer – a reality in real life populations?
Ramos, S.; Varregoso, J.; Carrasquinho Gomes, F.; Barcelos, A. Elsevier Science B.V., Amsterdam. 2018 p.e2824
Active surveillance: Prognostic factors
Fernández Garay, J.C.; Martínez Muñóz, R.; Rull Hernández, J.; Vidal Crespo, N.; López González, P.Á.; Gómez Gómez, G.A. Elsevier Science B.V., Amsterdam. 2018 p.e2834
Adaptive radiotherapy for carcinoma of the urinary bladder: Long term outcomes with dose escalation
Murthy, V.; Gupta, P.; Baruah, K.; Krishnatry, R.; Bakshi, G.; Prakash, G.; Pal, M.; Joshi, A.; Prabhash, K. Elsevier Science B.V., Amsterdam. 2018 p.e2976
Malmström, P.-U.; Westergren, D.-O.; Gårdmark, T.; Lindhagen, L.; Chau, A. Elsevier Science B.V., Amsterdam. 2018 p.e2784
Antialgic radiotherapy in castration resisten prostate cancer. A university hospital experience
Salas, M.C.; Gutiérrez, L.; Garduño, S.; Macías, M.J.; Rodriguez, R.; Sayago, S.; Gonzalez, E.; Díaz, V.; Villanego, I.; Jaén, J. Elsevier Science B.V., Amsterdam. 2018 p.e2885
Goncharuk, D.; Veliev, E.; Sokolov, E.; Shabunin, I.; Paklina, O.; Setdikova, G.; Semiletov, N. Elsevier Science B.V., Amsterdam. 2018 p.e2812